非酒精性脂肪性肝病向肝纤维化转变中自噬通路的分子机制
摘要
关键词
全文:
PDF参考
[1]袁淑敏,欧阳小芳,秦浩,李东升,占婷,刘蒙,韩峥,田霞.血浆致动脉粥样硬化指数预测非酒精性脂肪性肝病患者冠心病风险的价值[J].实用临床医药杂志,1-6.
[2]陈宪明,吴兴妹.护肝片联合熊去氧胆酸治疗非酒精性脂肪性肝炎疗效观察[C]//中国中西医结合学会消化系统疾病专业委员会.第二十四届全国中西医结合消化系统疾病学术会议专题报告及论文集.台州市博爱医院消化内科;,2012:366-368.
[3]华晓萍,刘亚欧,张媛,曹毓.蛋氨酸胆碱缺乏饲料联合肝损伤药物诱导小鼠非酒精性脂肪性肝病模型研究[J].中药药理与临床,1-19.
[4]易文霞,黄菊.超声衰减系数成像定量评估非酒精性脂肪肝的价值[J].影像研究与医学应用,2022,6(24): 24-26.
[5]张金花,王文宝,辛星.穴位贴敷联合运动疗法治疗混合痔术后便秘的效果[J].医药前沿,2024,14 (13):108-110.
[6]郭才,郑兰兰,何燕芳,谢娇娇,高芬,于春,马燕花.基于AMPK/mTOR/ERRα信号通路探讨慈菇消脂方影响非酒精性脂肪性肝炎小鼠肝细胞自噬作用机制[J].中国中医药信息杂志,2024,31(05):99-104.
[7]延华,柴春艳,张丹,赵媛,李敏.基于JNK信号通路探讨自噬、胰岛素抵抗在非酒精性脂肪性肝病中的发病机制[J].陕西医学杂志,2023,52(11):1506-1510.
[8]Feifei G,Olga E,Raquel B,et al.A Shortcut from Metabolic-Associated Fatty Liver Disease(MAFLD)to Hepatocellular Carcinoma(HCC):c-MYC a Promising Target for Preventative Strategies and Individualized Therapy[J].Cancers,2021,14(1):192-192.
[9]Vallianou Natalia,Christodoulatos Gerasimos Socrates,Karampela Irene,Tsilingiris Dimitrios,Magkos Faidon,Stratigou Theodora,Kounatidis Dimitris,Dalamaga Maria.Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease:Current Evidence and Perspectives[J].Biomolecules,2021,12(1):56-56.
[10]Park JiWon,Kim SungEun,Lee Na Young,Kim JungHee,Jung JangHan,Jang MyoungKuk,Park SangHoon,Lee MyungSeok,Kim DongJoon,Kim HyoungSu,Suk Ki Tae.Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases[J].International Journal of Molecular Sciences,2021,23(1):426-426.
[11]Wang Linlin,Jiao Ting,Yu Qiangqing,Wang Jialiang,Wang Luyao,Wang Gang,Zhang Hao,Zhao Jianxin,Chen Wei.Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis[J].Biomedicines,2021,10(1):84-84.
Refbacks
- 当前没有refback。